Cyclophosphamide/vincristineLack of efficacy: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2025年 / 2046卷 / 1期

关键词：

D O I：

10.1007/s40278-025-77508-8

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：120 / 120

相关论文

共 50 条

[41] Carboplatin/Etoposide/VincristineLack of efficacy: case report
Reactions Weekly, 2025, 2047 (1) : 104 - 104
[42] Idarubicin/prednisone/vincristineLack of efficacy: case report
Reactions Weekly, 2022, 1909 (1) : 279 - 279
[43] Carboplatin/etoposide/vincristineLack of efficacy: case report
Reactions Weekly, 2024, 2035 (1) : 134 - 134
[44] Bendamustine/Cyclophosphamide/Methotrexate/Prednisone/Rituximab/VincristineLack of efficacy: 2 case reports
Reactions Weekly, 2025, 2050 (1) : 109 - 109
[45] Doxorubicin/lenalidomide/vincristineLack of efficacy and skin irritation: case report
Reactions Weekly, 2023, 1984 (1) : 204 - 204
[46] Cyclophosphamide/dactinomycin/vincristineLack of efficacy and drug exposure during pregnancy
Reactions Weekly, 2023, 1987 (1) : 84 - 84
[47] Dactinomycin/sunitinib/vincristineLack of efficacy and change in hair colour: case report
Reactions Weekly, 2022, 1935 (1) : 173 - 173
[48] Methylprednisolone/vincristineLack of efficacy: 3 case reports
Reactions Weekly, 2020, 1819 (1) : 176 - 176
[49] Cyclophosphamide/doxorubicin/vincristineLack of efficacy in primary ocular adnexal double expression diffuse large B-cell lymphoma: case report
Reactions Weekly, 2020, 1830 (1) : 125 - 125
[50] Cyclophosphamide/methylprednisoloneLack of efficacy: case report
Reactions Weekly, 2023, 1946 (1) : 189 - 189

← 1 2 3 4 5 →